The Intensix platform is a pioneering platform of analytical tools that provides operational, financial and clinical benefits to all layers of ICU management and staff. Intensix utilizes high volume and velocity analytics to identify real-time patterns in physiological data that is used to predict a deterioration in the patient’s condition. By providing clinicians with early prediction of deteriorations, clinicians will be able to intervene sooner and consequently prevent unnecessary complications and ultimately, save lives. Deployed as a standalone app or integrated into an existing solution, the platform harnesses the vast amount of available ICU data to deliver highly accurate predictive clinical analytics that provide hospital management and medical personnel with the preemptive information they require to better manage the ICU floor. The Intensix solution is expected to reduce the average length of stay, a benefit that directly lowers the hospitals’ costs, and frees up revenue-producing ICU beds for other patients.

Company News

FDA greenlights ICU AI for predicting fatal COVID-19 complications

DateMay 28, 2020
The company’s CLEWICU artificial intelligence software ingests a large range of patient data by linking to electronic medical records, connected medical devices and vital sign monitors, with no need for additional data entry by ICU staff. The FDA also said the standalone CLEWICU software, based within the hospital or in the cloud, could help reduce contact between healthcare workers and COVID-19 patients through remote monitoring.
Read More →

Intensix Raises $8.3M in Series A

DateFeb 9, 2017
Medical analytics platform developer Intensix said today it raised $8.3 million in a Series A financing round with funds slated to boost sales and marketing in North America and to accelerate development of its predictive analytics platform.